Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
5.13
-0.22 (-4.11%)
At close: Jan 14, 2025, 4:00 PM
4.990
-0.140 (-2.73%)
After-hours: Jan 14, 2025, 6:30 PM EST
Personalis Employees
As of December 31, 2023, Personalis had 225 total employees, including 223 full-time and 2 part-time employees. The number of employees decreased by 174 or -43.61% compared to the previous year.
Employees
225
Change (1Y)
-174
Growth (1Y)
-43.61%
Revenue / Employee
$388,840
Profits / Employee
-$406,413
Market Cap
364.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PSNL News
- 1 day ago - New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer - Business Wire
- 7 days ago - Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue - Business Wire
- 26 days ago - Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna - Business Wire
- 4 weeks ago - Personalis and Tempus Expand Collaboration to Biopharma - Business Wire
- 7 weeks ago - Personalis to Participate at Upcoming Investor Conferences - Business Wire
- 2 months ago - Personalis, Inc. (PSNL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Personalis Reports Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - Personalis to Present at the Stifel 2024 Healthcare Conference - Business Wire